Aster DM Healthcare Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Consolidate Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Net Sales

1,182.38

1,185.76

1,197.21

1,077.87

1,000.34

1,049.81

1,086.44

Other Operating Income

0.00

Total Operating income

1,182.38

1,185.76

1,197.21

1,077.87

1,000.34

1,049.81

1,086.44

Raw Material Cost

0.00

Purchase of Finished goods

258.97

270.44

271.05

247.15

218.17

232.04

244.66

(Increase) / Decrease In Stocks

4.19

-2.96

-0.04

-0.01

7.06

14.97

-7.18

Employee Cost

219.99

221.37

211.92

194.81

182.96

193.64

193.35

Power Cost

0.00

Manufacturing Expenses

5.35

8.28

6.13

7.76

6.99

7.65

8.97

Selling and Distribution Expenses

264.66

270.36

257.15

239.70

229.98

229.39

235.89

Other Expenses

196.64

207.02

201.16

181.10

163.11

182.94

191.01

Total Expenditure (Excl Depreciation)

949.80

974.51

947.37

870.51

808.27

860.63

866.70

Operating Profit (PBDIT) excl Other Income

232.58

211.25

249.84

207.36

192.07

189.18

219.74

Other Income

36.20

27.97

28.25

33.18

31.28

32.99

35.24

Operating Profit (PBDIT)

268.78

239.22

278.09

240.54

223.35

222.17

254.98

Interest

29.99

31.46

30.76

30.77

32.43

30.77

31.46

Exceptional Items

0.33

-28.29

-0.36

-4.39

-26.42

-23.72

0.00

Gross Profit (PBDT)

239.12

179.47

246.97

205.38

164.50

167.68

223.52

Depreciation

67.24

67.67

66.12

63.22

63.95

62.21

62.27

Profit Before Tax

163.35

103.05

166.85

136.44

90.54

101.88

158.65

Tax

9.77

44.40

45.54

42.88

5.00

37.49

52.89

Provisions and contingencies

0.00

Profit After Tax

162.11

67.40

135.31

99.28

95.55

67.98

108.36

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

162.11

67.40

135.31

99.28

95.55

67.98

108.36

Share in Profit of Associates

-8.53

-8.75

-14.00

-5.72

-10.01

-3.59

-2.60

Minority Interest

13.41

6.20

11.31

8.04

6.52

7.60

8.92

Other related items

0.00

Consolidated Net Profit

140.17

52.45

110.00

85.52

79.02

56.79

96.84

Equity Capital

518.13

499.52

Face Value

10.0

Reserves

0.00

Earnings per share (EPS)

2.71

1.01

2.12

1.65

1.58

1.14

1.94

Diluted Earnings per share

2.71

1.02

2.13

1.67

1.58

1.14

1.94

Operating Profit Margin (Excl OI)

19.67%

17.82%

20.87%

19.24%

19.2%

18.02%

20.23%

Gross Profit Margin

20.22%

15.14%

20.63%

19.05%

16.44%

15.97%

20.57%

PAT Margin

12.99%

4.95%

10.13%

8.68%

8.55%

6.13%

9.73%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Mar 2026 is 18.20% vs 2.75% in Mar 2025

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 77.39% vs 428.84% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 21.09% vs 20.54% in Mar 2025

Interest

YoY Growth in quarter ended Mar 2026 is -7.52% vs 8.53% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Aster DM Health. With

Select Peers

Figures in Cr

Consolidate Quarterly Results

Change(INR)

Change(%)

Net Sales

1,182.38

2,265.01

-1,082.63

-47.80%

Other Operating Income

0.00

Total Operating income

1,182.38

2,265.01

-1,082.63

-47.80%

Raw Material Cost

0.00

522.23

-522.23

-100.00%

Purchase of Finished goods

258.97

0.00

258.97

(Increase) / Decrease In Stocks

4.19

-6.09

10.28

168.80%

Employee Cost

219.99

327.58

-107.59

-32.84%

Power Cost

0.00

Manufacturing Expenses

5.35

493.54

-488.19

-98.92%

Selling and Distribution Expenses

264.66

0.00

264.66

Other Expenses

196.64

422.10

-225.46

-53.41%

Total Expenditure (Excl Depreciation)

949.80

1,759.36

-809.56

-46.01%

Operating Profit (PBDIT) excl Other Income

232.58

505.65

-273.07

-54.00%

Other Income

36.20

8.29

27.91

336.67%

Operating Profit (PBDIT)

268.78

513.94

-245.16

-47.70%

Interest

29.99

85.74

-55.75

-65.02%

Exceptional Items

0.33

-45.91

46.24

100.72%

Gross Profit (PBDT)

239.12

382.29

-143.17

-37.45%

Depreciation

67.24

120.14

-52.90

-44.03%

Profit Before Tax

163.35

265.68

-102.33

-38.52%

Tax

9.77

68.28

-58.51

-85.69%

Provisions and contingencies

0.00

Profit After Tax

162.11

193.87

-31.76

-16.38%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

162.11

193.87

-31.76

-16.38%

Share in Profit of Associates

-8.53

3.53

-12.06

-341.64%

Minority Interest

13.41

3.67

9.74

265.40%

Other related items

0.00

Consolidated Net Profit

140.17

193.73

-53.56

-27.65%

Equity Capital

518.13

754.96

-236.83

-31.37%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

2.71

2.57

0.14

5.45%

Diluted Earnings per share

2.71

2.57

0.14

5.45%

Operating Profit Margin (Excl OI)

19.67%

22.32%

0.00

-2.65%

Gross Profit Margin

20.22%

16.88%

0.00

3.34%

PAT Margin

12.99%

8.72%

0.00

4.27%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 1,182.38 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -0.29% vs -0.96% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 18.20% vs 2.75% in Mar 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 140.17 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 167.24% vs -52.32% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 77.39% vs 428.84% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 232.58 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 10.10% vs -15.45% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 21.09% vs 20.54% in Mar 2025

Quarterly - Interest

Interest 29.99 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -4.67% vs 2.28% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -7.52% vs 8.53% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 19.67%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025